User talk:Rahulsoman

Page contents not supported in other languages.
From Wikipedia, the free encyclopedia

A junior Wikipedian, So feel free to make your discussion here, before typing please sign in your post with ~~~~. I'm a beginner so waiting for a productive discussion.

My mentor once told me, "If you got a revision to your article and you wrote a reply with in 24 hours then it will only be an emotional outburst, there wont be any science or philosophy :). Because that time you only will think about the pain you experienced while writing the article. So always give reply to the reviewers and editors, only after some period of time. But unfortunately I am not following that here. sometimes I may write something here our fellow editors talk pages. Just leave it and consider it as only my emotional outburst.

Thanks!

Please click here to leave me a new message.

Remember to sign your post with ~~~~

Archives[edit]

Archive_1

Your submission at Articles for creation: Diamond (crystallography) (September 26)[edit]

Your recent article submission to Articles for Creation has been reviewed! Unfortunately, it has not been accepted at this time. The reason left by Liance was:
This submission's references do not show that the subject qualifies for a Wikipedia article—that is, they do not show significant coverage (not just passing mentions) about the subject in published, reliable, secondary sources that are independent of the subject. Before any resubmission, additional references meeting these criteria should be added (see technical help and learn about mistakes to avoid when addressing this issue). If no additional references exist, the subject is not suitable for Wikipedia.
Please check the submission for any additional comments left by the reviewer. You are encouraged to edit the submission to address the issues raised and resubmit when they have been resolved.
-Liancetalk/contribs 21:06, 26 September 2021 (UTC)[reply]
Hi Liance, Thanks for reviewing the article, I will continue editing the article and I believe it's useful software for researchers working in the field of crystallography. Found the major reason for rejection is related to its importance and citations. I am adding few of the neutral citations below which I have already cited in the article.

References

Rahulsoman (talk) 22:17, 26 September 2021 (UTC)[reply]

I moved the draft to Draft:Diamond (crystallography software) for clarity--otherwise it would seem to refer to the crystal structure of Diamondss, which is covered in the main article.

Hi [User:DGG|DGG]] sir, is it possible to accept the article. Rahulsoman (talk) 18:24, 30 November 2021 (UTC)[reply]

Links to draft articles[edit]

Information icon Please do not introduce links in actual articles to draft articles, as you did to CrystalExplorer and Mercury (crystallography). Since a draft is not yet ready for the main article space, it is not in shape for ordinary readers, and links from articles should not go to a draft. Such links are contrary to the Manual of Style. These links have been removed. Thank you. - Arjayay (talk) 21:23, 26 September 2021 (UTC)[reply]

Arjayay Thanks for the information. Now I plan to delete the draft file, I will be removing the links given in CrystalExplorer, Mercury (crystallography) etc. Rahulsoman (talk)

check[edit]

https://en.m.wikipedia.org/w/index.php?title=Special:AdvancedReviewLog&namespace=0&user=&status=-1&automatic=0

check Rahulsoman (talk) 21:16, 5 October 2021 (UTC)[reply]

Remake tables[edit]

Please don't create remake tables including cast members. Just let them have the year, title, language and refs. Also, add such tables only at the original film's article, not at the remakes'. Kailash29792 (talk) 15:56, 7 October 2021 (UTC)[reply]

So you removed it from everywhere ( [1]

[2] [3] [4] ). I could not see the same rule anywhere here in wiki. Can you share it. I saw your template, but the drawback of the template is it won't appear everywhere (in mobile versions and all) So I created an elaborate table.

Check your Email[edit]

Hello, Please Check Email in your device !!! I have sent you a deal about science fiction collaboration in Wikipedia. Thanks Regards, 0"cleopatra"0 (talk) 11:38, 21 October 2021 (UTC)[reply]

Reply[edit]

Hi 0"cleopatra"0 (talk, Happy to read your mail, all the best for your degree. Gone through your page ( https://xtools.wmflabs.org/ec/en.wikipedia.org/0%22cleopatra%220 ) and found your activities and contributions.

Interested to collaborate with you but currently I am not in a position to contribute more here Medicine Subjects, Chapters and Topics (MBBS).

While making the new article, follow the complete procedures, go through " Wikipedia:WikiProject_Articles_for_creation/Help_desk "

All the best.

AfC notification: Draft:Theranostics has a new comment[edit]

I've left a comment on your Articles for Creation submission,, as follows:

We already cover this as a section of the article on Personalized medicine, though that is almost certainly not a good place for it, it is furthermore confused using both Theranostics and radiotheranostics-- every example given is radiotheranostics. So it does make sense to have a separate article.

We also already have an article on the journal.

Nanotheranostics needs to be distinguished more clearly-- much of what is listed here is simply a small molecule. The separate sections on diagnostic and therapeutic agents are mostly methods used only for diagnosis--for example , PET is not therapy and therefore cannot be a part of theragnostics. It an be used as part of the work-up, but so can everything else, and the same applies to almost every thing listed there. I think it would be much clearer to simple list the accepted agents that do fall within theragnostics. It also needs to be clarified that almost everything here is mostly discussed in the literature without using this term.

It should refer to the articles on them for the details..(though we need an article on Gallium 68Ga PSMA-11. and possibly others)

Style is a problem: some of the sentences have missing words, and Capitals are Used Inappropriately. Effect and Affect are confused. Phrases such as "this clearly indicates the huge research output generated in the field of theranostics research." are judgement. and we don't do that.

I don't like to decline a draft for style or organization, but in this case it needs reorganization to the extent that it is unclear in its present form. DGG ( talk ) 23:37, 7 November 2021 (UTC)[reply]

. Thanks! DGG ( talk ) 23:36, 7 November 2021 (UTC)[reply]

Reply to Respected DGG Sir[edit]

Thanks a lot for reading and reviewing the article in details.

Reply1: existing page Personalized medicine[edit]

The topic "theranostics" is covered peripherally in Personalized medicine, I am a person doing research in theranostics. Always I used to feel it very odd while seeing it as a part of Personalized medicine. It is a very huge research area and still it is not having its own existence in the wiki is not good I felt sir.

Reply: confused using both Theranostics and radiotheranostics[edit]

  • Theranostics is a broader term and radiotheranostics is its further division. Just like therapy is broader term where radiotherapy is its one classification.
  • Actually in theranostics, recent growth is shown mainly by radiotheranostics, because FDA approved medicines and all are coming in this area. Sad to say other MRI theranostics based applications ( ex: Motexafin gadolinium) to FDA got failed that I dint mention in the article purposefully not to hurt the respected scientists and the company.

Reply; So it does make sense to have a separate article about radiotheranostics[edit]

  • Definitely I too believe there should be a separate article on radiotheranostics but priorly this page should be accepted. Because radiotheranostics is only a subdivision of theranostics. So lets build a page on theranostics first.

Reply: We also already have an article on the journal.[edit]

Journal title itself is Theranostics, which clearly shows the importance of the research area.

Nanotheranostics[edit]

It will be done, but so far FDA approved Nanotheranostics are not yet there. So for public or general awareness its not much important. Many successful laboratory models are there still its not a

PET is not therapy and therefore cannot be a part of theragnostics[edit]

  • PET is an imaging technique that is used for diagnosis. Not only that in modern studies PET varients are effective in diagnosis, monitoring treatment of cancers, particularly in Hodgkin lymphoma,[1] non-Hodgkin lymphoma,[2] and lung cancer.[3][4][5]
  • So it is an effective tool in theragnostics. You can refer to any article about theregnostics it will be clearly visible there.

we need an article on Gallium 68Ga PSMA-11[edit]

certainly its needed.

Style is a problem[edit]

As a villager rural Indian, I might have made mistakes in the writing, the content I shared here is true and I have real experience in it. I developed and filed an Indian Patent on theranostics ( Rahul Soman, Chandra, B., Ishfaq, A. B., Raveendra, Babu M., Pradeepta K. Panda. Process for the preparation of fluorescent B(III)subchlorins dyes and utility as theranostics for biomedical applications. Indian Patent with Application 202041048863, 2020 ) Last 6 years of time we spend on the work and still continuing.

References[edit]

  1. ^ Zaucha JM, Chauvie S, Zaucha R, Biggii A, Gallamini A (July 2019). "The role of PET/CT in the modern treatment of Hodgkin lymphoma". Cancer Treatment Reviews. 77: 44–56. doi:10.1016/j.ctrv.2019.06.002. PMID 31260900.
  2. ^ McCarten KM, Nadel HR, Shulkin BL, Cho SY (October 2019). "Imaging for diagnosis, staging and response assessment of Hodgkin lymphoma and non-Hodgkin lymphoma". Pediatric Radiology. 49 (11): 1545–1564. doi:10.1007/s00247-019-04529-8. PMID 31620854. S2CID 204707264.
  3. ^ Pauls S, Buck AK, Hohl K, Halter G, Hetzel M, Blumstein NM, et al. (2007). "Improved non-invasive T-Staging in non-small cell lung cancer by integrated18F-FDG PET/CT". Nuklearmedizin. 46 (1): 09–14. doi:10.1055/s-0037-1616618. ISSN 0029-5566.
  4. ^ Steinert HC (2011). "PET and PET-CT of lung cancer". Positron Emission Tomography. Methods in Molecular Biology. Vol. 727. Humana Press. pp. 33–51. doi:10.1007/978-1-61779-062-1_3. ISBN 978-1-61779-061-4. PMID 21331927.
  5. ^ Chao F, Zhang H (2012). "PET/CT in the staging of the non-small-cell lung cancer". Journal of Biomedicine & Biotechnology. 2012: 783739. doi:10.1155/2012/783739. PMC 3346692. PMID 22577296.

November 2021[edit]

Information icon Thank you for your contributions. It seems that you may have added public domain content to one or more Wikipedia articles, such as Draft:Gallium 68 PSMA-11. You are welcome to import appropriate public domain content to articles, but in order to meet the Wikipedia guideline on plagiarism, such content must be fully attributed. This requires not only acknowledging the source, but acknowledging that the source is copied. There are several methods to do this described at Wikipedia:Plagiarism#Public-domain sources, including the usage of an attribution template. Please make sure that any public domain content you have already imported is fully attributed. Thank you. Moneytrees🏝️Talk/CCI guide 21:00, 9 November 2021 (UTC)[reply]

The Draft:Gallium 68 PSMA-11 article is not yet submitted, just started working on it that's all.Rahulsoman (talk) 21:12, 9 November 2021 (UTC)[reply]
Moneytrees🏝️ Sir Submitted the article now only. Rahulsoman (talk) 06:41, 10 November 2021 (UTC)[reply]

Concern regarding Draft:Sandhya Mohan[edit]

Information icon Hello, Rahulsoman. This is a bot-delivered message letting you know that Draft:Sandhya Mohan, a page you created, has not been edited in at least 5 months. Drafts that have not been edited for six months may be deleted, so if you wish to retain the page, please edit it again or request that it be moved to your userspace.

If the page has already been deleted, you can request it be undeleted so you can continue working on it.

Thank you for your submission to Wikipedia. FireflyBot (talk) 12:03, 11 November 2021 (UTC)[reply]

Gallium 68 PSMA-11 structures[edit]

ball and stick representation of mol image of Gallium 68 PSMA-11

Your submission at Articles for creation: Gallium 68 PSMA-11 (November 12)[edit]

Your recent article submission to Articles for Creation has been reviewed! Unfortunately, it has not been accepted at this time. The reason left by DGG was:
This does not meet the requirements of MEDRS.

You need to write first about it as a chemical, and after that about the therapeutic use. For the portion on therapeutic use, everything must meet the requirements at MedRS. In particular, saying that it is the drug of choice is not compatible with it being the only approved drug. Whichever, you need specific statements to that effect from a MEDRS reliable published source. If it's the procedure of choice, you need to say what it replaces, and that using this drug is the procedure of choice, and have a good source for that also. Nor can you discuss risk without a good source, and you need to give some indication from a source on the degree of risk. . In either case, considerably more detail will be needed.

Respected Sir, thanks for the productive comments, found a lot to learn about MEDRS. Now the first paragraph is modified accordingly. The drug is only recently approved by US-FDA, currently its in clinical trial phase IV, so cited mainly the USFDA free accessible data and medical journal reviews. The remaining references and the degree of risk were removed as per MEDRS.

You're good at writing articles on chemicals, and you're an expert in the field, we need more, and I shall refer incomplete drafts on that subject to you for improvment. . But drug articles are special--they're part of medical therapy or diagnostics, and they have particularly strict rules to ensure we give only truly reliable information, not speculations based on a single published paper. (That necessarily makes us very conservative, and sometimes behind the times, but it can't be helped). The problem in writing about them is to avoid any feeling of enthusiasm or promotionalism, but write very plainly without indicating any excitement. I know it's routine in writing a paper to say something about potential medical use, as a hook for getting grants to develop it further -- i've done that myself--but we do not do it here. ) But what you need not and should not discuss is the impact of the disease-- a link will do for that. What would be very helpful to know is the approval status in other coutnries, for WP covers the entire world, not just the US. (at least the major English-speaking countries)

Thanks and happy for the compliment Sir, I am interested to write and improve wiki content no doubt. By believing, I have a pharmacy background, I added the content (I have a Postgraduation in Pharmacy, worked in Govt hospital as Pharmacist and a registered pharmacist in India. I quit the job and done PhD in porphyrin chemistry from NIT Calicut, then moved for Postdoctoral studies in PDT based theranostics at the University of Hyderabad. Doing research for last 11 years, Sir if you felt the article it like a promotion sorry for that, I hope now I corrected it). In any manner, I don't want to promote this medicine, if you felt enthusiasm in writing I removed it and made it very plain. Also removed the impact of the disease as you told. In other countries, it's not yet accepted, European Pharmacopoeia mentions, simple Gallium (68Ga) chloride solution for radiolabelling [5] similar class of radiopharmaceutical but target action won't be there. If needed we can add it here but I feel it is not needed. (don't limit en.WP. it is very much popular among non-English speaking Indian's :) )Rahulsoman (talk) 20:27, 18 November 2021 (UTC)[reply]
Include the reference with the information you just said. And say that the US is the first country to approve it. DGG ( talk ) 01:58, 19 November 2021 (UTC)[reply]
Just gone through European Pharmacopoeia 10.0 and found two 68-Ga substituents for radiolabelling (Radiolabelling, gallium (68Ga) chloride solution Page 1206 and DOTATOC (gallium (68Ga)) injection Page 1208). Please find the index [6]


I perhaps should mention that I try to look for articles on these topics to review, for I have a doctorate in biochem/mol bio, from Berkeley, and was the biochem librarian at Princeton for 20 years--and was the chemistry librarian as well for about half of that.

Great to know about you Sir, I am only a beginner, really feels great by reading and communicate with people like you here.Rahulsoman (talk)
Please check the submission for any additional comments left by the reviewer. You are encouraged to edit the submission to address the issues raised and resubmit when they have been resolved.
  • If you would like to continue working on the submission, go to Draft:Gallium 68 PSMA-11 and click on the "Edit" tab at the top of the window.
DGG ( talk ) 08:17, 12 November 2021 (UTC)[reply]
Teahouse logo
Hello, Rahulsoman! Having an article declined at Articles for Creation can be disappointing. If you are wondering why your article submission was declined, please post a question at the Articles for creation help desk. If you have any other questions about your editing experience, we'd love to help you at the Teahouse, a friendly space on Wikipedia where experienced editors lend a hand to help new editors like yourself! See you there! DGG ( talk ) 08:17, 12 November 2021 (UTC)[reply]

How should communication work in the Wikipedia Android app?[edit]

Hi!

You are getting this message because you are a user of the Wikipedia Android app and have edited Wikipedia through the app. We are working on notifications in the app. This is important because it helps others to contact you to help you or discuss something with you. If you are interested and have time, we would be very interested in your feedback on how to best improve communication in the app. You can answer our survey on mediawiki.org or in Google Forms.

Thank you. For the Android team, Johan (WMF).

17:28, 16 November 2021 (UTC)

Sir, I used to edit in Android version rarely and I have already answered the quarries in google forms. Rahulsoman (talk) 17:35, 16 November 2021 (UTC)[reply]

ArbCom 2021 Elections voter message[edit]

Hello! Voting in the 2021 Arbitration Committee elections is now open until 23:59 (UTC) on Monday, 6 December 2021. All eligible users are allowed to vote. Users with alternate accounts may only vote once.

The Arbitration Committee is the panel of editors responsible for conducting the Wikipedia arbitration process. It has the authority to impose binding solutions to disputes between editors, primarily for serious conduct disputes the community has been unable to resolve. This includes the authority to impose site bans, topic bans, editing restrictions, and other measures needed to maintain our editing environment. The arbitration policy describes the Committee's roles and responsibilities in greater detail.

If you wish to participate in the 2021 election, please review the candidates and submit your choices on the voting page. If you no longer wish to receive these messages, you may add {{NoACEMM}} to your user talk page. MediaWiki message delivery (talk) 00:36, 23 November 2021 (UTC)[reply]

Sorry MediaWiki message delivery, right now I am not knowing much about elections, so not ready to put vote.

Your submission at Articles for creation: Oru Thathvika Avalokanam (December 6)[edit]

Your recent article submission to Articles for Creation has been reviewed! Unfortunately, it has not been accepted at this time. The reason left by Slywriter was:
This submission's references do not show that the subject qualifies for a Wikipedia article—that is, they do not show significant coverage (not just passing mentions) about the subject in published, reliable, secondary sources that are independent of the subject (see the guidelines on the notability of films). Before any resubmission, additional references meeting these criteria should be added (see technical help and learn about mistakes to avoid when addressing this issue). If no additional references exist, the subject is not suitable for Wikipedia.
 The comment the reviewer left was:
Upcoming... Unlikely to be notable until its actually released
Please check the submission for any additional comments left by the reviewer. You are encouraged to edit the submission to address the issues raised and resubmit when they have been resolved.
Slywriter (talk) 21:00, 6 December 2021 (UTC)[reply]

Cast names in film plots[edit]

Information icon Please refrain from making unconstructive edits to Wikipedia, as you did at Love Action Drama . Your edits appear to constitute vandalism and have been reverted. Repeated vandalism may result in the loss of editing privileges.
Please do not add actors names in the plot section of films as this is contrary to WP:FILMPLOT "Do not include actors' names in the plot summary" - Thank you Aadirulez8 (talk) 17:51, 9 January 2022 (UTC)[reply]

Hi Aadirulez8 (talk), thanks for that information. I wont be performing such edits. Rahulsoman (talk) 15:00, 12 January 2022 (UTC)[reply]

Your submission at Articles for creation: Theranostics (February 17)[edit]

Your recent article submission to Articles for Creation has been reviewed! Unfortunately, it has not been accepted at this time. The reason left by Slywriter was:
This submission does not appear to be written in the formal tone expected of an encyclopedia article. Entries should be written from a neutral point of view, and should refer to a range of independent, reliable, published sources. Please rewrite your submission in a more encyclopedic format. Please make sure to avoid peacock terms that promote the subject.
 The comment the reviewer left was:
Future and Outlook section written like trying to sell something to the reader. Concepts.. "As we mentioned earlier" is not a good tone. After all, whose we and when is earlier
Please check the submission for any additional comments left by the reviewer. You are encouraged to edit the submission to address the issues raised and resubmit when they have been resolved.
Slywriter (talk) 14:51, 17 February 2022 (UTC)[reply]

Your submission at Articles for creation: Gallium 68 PSMA-11 has been accepted[edit]

Gallium 68 PSMA-11, which you submitted to Articles for creation, has been created.

Congratulations, and thank you for helping expand the scope of Wikipedia! We hope you will continue making quality contributions.

The article has been assessed as Start-Class, which is recorded on its talk page. Most new articles start out as Stub-Class or Start-Class and then attain higher grades as they develop over time. You may like to take a look at the grading scheme to see how you can improve the article.

Since you have made at least 10 edits over more than four days, you can now create articles yourself without posting a request. However, you may continue submitting work to Articles for creation if you prefer.

If you have any questions, you are welcome to ask at the help desk. Once you have made at least 10 edits and had an account for at least four days, you will have the option to create articles yourself without posting a request to Articles for creation.

If you would like to help us improve this process, please consider leaving us some feedback.

Thanks again, and happy editing!

– robertsky (talk) 03:26, 5 March 2022 (UTC)[reply]


really Thanks – robertsky (talk) for giving happy newz after a long time.

Rahulsoman (talk)

Your draft article, Draft:Sandhya Mohan[edit]

Hello, Rahulsoman. It has been over six months since you last edited the Articles for Creation submission or Draft page you started, "Sandhya Mohan".

In accordance with our policy that Wikipedia is not for the indefinite hosting of material deemed unsuitable for the encyclopedia mainspace, the draft has been deleted. If you plan on working on it further and you wish to retrieve it, you can request its undeletion. An administrator will, in most cases, restore the submission so you can continue to work on it.

Thanks for your submission to Wikipedia, and happy editing. Liz Read! Talk! 23:28, 11 May 2022 (UTC)[reply]

Hi Wishing happy editing by deleting article, but its okay Liz.
Regards
Rahulsoman (talk) 15:37, 13 May 2022 (UTC)[reply]

Your draft article, Draft:Diamond (crystallography software)[edit]

Hello, Rahulsoman. It has been over six months since you last edited the Articles for Creation submission or Draft page you started, "Diamond".

In accordance with our policy that Wikipedia is not for the indefinite hosting of material deemed unsuitable for the encyclopedia mainspace, the draft has been deleted. If you plan on working on it further and you wish to retrieve it, you can request its undeletion. An administrator will, in most cases, restore the submission so you can continue to work on it.

Thanks for your submission to Wikipedia, and happy editing. Liz Read! Talk! 23:30, 27 May 2022 (UTC)[reply]

Ok thanks Liz Rahulsoman (talk) 03:28, 31 May 2022 (UTC)[reply]

June 2022[edit]

Information icon Please refrain from making test edits in Wikipedia pages, such as those you made to Anil Kumar (physicist), even if you intend to fix them later. Your edits have been reverted. If you would like to experiment again, please use your sandbox. Thank you. Dl2000 (talk) 00:44, 8 June 2022 (UTC)[reply]

Sure,
Dl2000, thanks for message.
Regards Rahulsoman (talk) 09:40, 8 June 2022 (UTC)[reply]

ArbCom 2022 Elections voter message[edit]

Hello! Voting in the 2022 Arbitration Committee elections is now open until 23:59 (UTC) on Monday, 12 December 2022. All eligible users are allowed to vote. Users with alternate accounts may only vote once.

The Arbitration Committee is the panel of editors responsible for conducting the Wikipedia arbitration process. It has the authority to impose binding solutions to disputes between editors, primarily for serious conduct disputes the community has been unable to resolve. This includes the authority to impose site bans, topic bans, editing restrictions, and other measures needed to maintain our editing environment. The arbitration policy describes the Committee's roles and responsibilities in greater detail.

If you wish to participate in the 2022 election, please review the candidates and submit your choices on the voting page. If you no longer wish to receive these messages, you may add {{NoACEMM}} to your user talk page. MediaWiki message delivery (talk) 01:10, 29 November 2022 (UTC)[reply]

Concern regarding Draft:Theranostics[edit]

Information icon Hello, Rahulsoman. This is a bot-delivered message letting you know that Draft:Theranostics, a page you created, has not been edited in at least 5 months. Drafts that have not been edited for six months may be deleted, so if you wish to retain the page, please edit it again or request that it be moved to your userspace.

If the page has already been deleted, you can request it be undeleted so you can continue working on it.

Thank you for your submission to Wikipedia. FireflyBot (talk) 15:01, 17 December 2022 (UTC)[reply]

Concern regarding Draft:Amrita School of Pharmacy[edit]

Information icon Hello, Rahulsoman. This is a bot-delivered message letting you know that Draft:Amrita School of Pharmacy, a page you created, has not been edited in at least 5 months. Drafts that have not been edited for six months may be deleted, so if you wish to retain the page, please edit it again or request that it be moved to your userspace.

If the page has already been deleted, you can request it be undeleted so you can continue working on it.

Thank you for your submission to Wikipedia. FireflyBot (talk) 03:01, 28 December 2022 (UTC)[reply]

Your draft article, Draft:Theranostics[edit]

Hello, Rahulsoman. It has been over six months since you last edited the Articles for Creation submission or Draft page you started, "Theranostics".

In accordance with our policy that Wikipedia is not for the indefinite hosting of material deemed unsuitable for the encyclopedia mainspace, the draft has been deleted. When you plan on working on it further and you wish to retrieve it, you can request its undeletion. An administrator will, in most cases, restore the submission so you can continue to work on it.

Thanks for your submission to Wikipedia, and happy editing. Liz Read! Talk! 17:10, 17 January 2023 (UTC)[reply]

Hi Mam,
Kindly let me know where I can find the deleted page (Draft:Theranostics). I worked a lot to create it so its better if I am able to recover it.
Regards
Soman Rahulsoman (talk) 08:28, 22 January 2023 (UTC)[reply]

ArbCom 2023 Elections voter message[edit]

Hello! Voting in the 2023 Arbitration Committee elections is now open until 23:59 (UTC) on Monday, 11 December 2023. All eligible users are allowed to vote. Users with alternate accounts may only vote once.

The Arbitration Committee is the panel of editors responsible for conducting the Wikipedia arbitration process. It has the authority to impose binding solutions to disputes between editors, primarily for serious conduct disputes the community has been unable to resolve. This includes the authority to impose site bans, topic bans, editing restrictions, and other measures needed to maintain our editing environment. The arbitration policy describes the Committee's roles and responsibilities in greater detail.

If you wish to participate in the 2023 election, please review the candidates and submit your choices on the voting page. If you no longer wish to receive these messages, you may add {{NoACEMM}} to your user talk page. MediaWiki message delivery (talk) 00:42, 28 November 2023 (UTC)[reply]

Retrieved from "https://en.wikipedia.org/w/index.php?title=User_talk:Rahulsoman&oldid=1187211042"